User:ColinMenzynski/sandbox

= Yvonne Greenstreet = Yvonne Greenstreet (Born 1964, in the United Kingdom) is the President and COO of Alnylam Pharmaceuticals. She is an accomplished business woman in the medical field, holding multiple titles throughout the companies she has worked for. She has more than 25 years of experience working in the pharmaceutical industry.

Education
She studied and received her MBA from INSEAD, France. She then went on and received her medical degree (MBChB) from the University of Leeds in the United Kingdom.

Career History
The first company that she worked for was GlaxoSmithKline (1993-2010). She held several titles while working there including Chief Medical Officer:Europe, Senior VP Medicine Development, and Senior VP/Chief of Strategy. Then she moved on and worked for Pfizer (February 2011-November 2013). She was Senior Vice President and Head of Medicines Development. She then went to work for Alnylam Pharmaceutical Inc. (September 2016-Present). She started off as Executive VP and COO until October 2020 when she was promoted to President. She is keeping her role as COO.

Board Memberships
She is currently serving on the Board of Directors for Parcira Pharmaceuticals and Indivor PLC. She serves on the Scientific Advisory Committee for the Bill and Melinda Gates Foundation.

Current Work
At Alynylam she is currently involved in the work on RNAi classes of medicine and trying to expand their possible uses in treating a number of diseases.